Charles F. Wagner, Jr.
Equibles does not estimate personal net worth.
Get an email with a short summary when Vertex Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get VRTX alertsAbout Charles F. Wagner, Jr.
Charles F. Wagner, Jr. is recorded as COO at Vertex Pharmaceuticals Inc (VRTX) since July 1, 2025. Vertex Pharmaceuticals Inc reported in an 8-K filed February 10, 2025 that Charles F. Wagner, Jr. was appointed Chief Operating Officer, effective July 1, 2025. Vertex Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vertex Pharmaceuticals Inc includes Dr. Reshma Kewalramani (CEO), Reshma Kewalramani (CEO and Board Member), Dr. Jeffrey M. Leiden (Chairman) and 7 others.
“The Company also announced the appointment of Charles F. Wagner, Jr. as Chief Operating Officer of the Company”
Affiliation history
-
Current
2025-07-01–present
Company network
Leadership on record at Vertex Pharmaceuticals Inc
- Dr. Reshma Kewalramani CEO
- Reshma Kewalramani CEO, Board Member
- Dr. Jeffrey M. Leiden Chairman
- Jeffrey Leiden Chairman, Board Member
- Charles Wagner CFO
- Jonathan Poole CFO
- Alan Garber Board Member
- Bruce Sachs Board Member
- Daniel Brennan Board Member
- Diana McKenzie Board Member